Analysis on molecular mechanisms of liver reconstitution by transplanted hepatic cells
Project/Area Number |
21590833
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Tokyo Medical and Dental University |
Principal Investigator |
AZUMA Seishin (CHEN Cheng-Hsin) 東京医科歯科大学, 医学部・附属病院, 助教 (10376783)
|
Co-Investigator(Kenkyū-buntansha) |
KAKINUMA Sei 東京医科歯科大学, 大学院・医歯学総合研究科, 寄附講座教員(講師) (30372444)
SAKAMOTO Naoya 東京医科歯科大学, 大学院・医歯学総合研究科, 寄附講座教員(准教授) (10334418)
WATANABE Mamoru 東京医科歯科大学, 大学院・医歯学総合研究科, 教授 (10175127)
|
Co-Investigator(Renkei-kenkyūsha) |
SUZUKI Shinji 東京医科歯科大学, 大学院・医歯学総合研究科, 助教 (10456212)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 肝臓学 / 再生医学 / 肝細胞 / 幹細胞 / 発生・分化 / 肝細胞移植 / CD13 |
Research Abstract |
Investigators of this research project have modulated the expression of target molecules of primary murine hepatic stem/progenitor cells purified by cell surface markers, and analyzed on the molecular mechanisms of liver repopulation by transplanted cells. We found that CD13 is a useful marker for enrichment of hepatic stem/progenitor cells. We also found that Sall4-mediated signaling pathway regulates the biliary differentiation of hepatic stem/progenitor cells. Our data indicated that modulation of MMP increases to the repopulation of recipient livers by donor cells. These studies contribute to the progress of autologous stem cell therapy against liver diseases.
|
Report
(4 results)
Research Products
(54 results)
-
[Journal Article] Data Mining Analysis of Hepatocellular Carcinoma Risk Predictors in Chronic Hepatitis C2012
Author(s)
Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sugauchi F, Sakamoto N, Nakagawa M, Izumi NHiramatsu N, Sakamoto M, Suzuki Y, iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sugauchi F, Sakamoto N
-
Journal Title
C.J Hepatol
Volume: 56(3)
Pages: 602-8
Related Report
-
[Journal Article] Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication2012
Author(s)
Kusano-Kitazume A, Sakamoto N, Okuno Y, Sekine-Osajima Y, Nakagawa M, Kakinuma S, Kiyonashi K, Nitta S, Murakawa M, Azuma S, Nishimura-Sakurai Y, Hagiwara M, Watanabe M
-
Journal Title
Antimicrob Agent Chemother
Volume: 56(3)
Pages: 1315-23
Related Report
-
[Journal Article] Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis2012
Author(s)
Kurosaki M, Hiramatsu N, Sakamoto M, Suzuki Y, Iwasaki M, Tamori A, Matsuura K, Kakinuma S, Sakaguchi F, Sakamoto N, Nakagawa M, Izumi N
-
Journal Title
C.J Hepatol
Volume: 56(3)
Pages: 602-8
Related Report
-
[Journal Article] Ochanomizu Liver Conference Study Group : Association of ITPA gene variant and serum ribavirin concentration with blood cells decline in pegylated interferon-alfa plus ribavirin therapy for chronic hepatitis C2012
Author(s)
Nakagawa M, Sakamoto N, Watanabe T, Nishimura-Sakurai Y, Onozuka I, Azuma S, Kakinuma S, Nitta S, Kiyohashi K, Kusano-Kitazume A, Murakawa M, Yoshino K, Itsui Y, Tanaka Y, Mizokami M, Watanabe M
-
Journal Title
Hepatol Int
Volume: (in press)
Related Report
-
[Journal Article] Association of gene expression involving innate immunity and genetic variation in IL28B with antiviral response2011
Author(s)
Asahina Y, Tsuchiya K, Muraoka M, TanakaK, Suzuki Y, Tamaki N, Hoshioka Y, Yasui Y, Katoh T, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Enomoto N, Nitta S, Sakamoto N, Izumi N
-
Journal Title
Hepatology
Volume: 55(1)
Pages: 20-29
Related Report
-
[Journal Article] Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice2011
Author(s)
Kakinuma S, Onozuka I, Kamiya A, Miyoshi M, Sakamoto N, Kiyohashi K, Watanabe T, Funaoka Y, Ueyama M, NakagawaM, Koshikawa N, Seiki M, Nakauchi H, and Watanabe M
-
Journal Title
Biochem Biophys Res Commun
Volume: 406
Pages: 134-140
Related Report
-
[Journal Article] Pre-treatment prediction of response topegylated-interferon plus ribavirin forchronic hepatitis C using genetic polymorphism in IL28B and viral factors2011
Author(s)
Kurosaki M, Tanaka Y, Nishida N, Sakamoto N, Enomoto N, Honda M, SugiyamaM, Matsuura K, Sugauchi F, Asahina Y, Nakagawa M, Watanabe M, Sakamoto M, Maekawa S, Sakai A, Kaneko S, Ito K, Masaki N, Tokunaga K, Izumi N, Mizokami M
-
Journal Title
JHepatol
Volume: 54
Pages: 439-448
Related Report
-
[Journal Article] Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 912011
Author(s)
Funaoka Y, Sakamoto N, Suda G, Itsui Y, Nakagawa M, Kakinuma S, Watanabe T, Nitta S, Kitazume A, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K, Watanabe M
-
Journal Title
J Virol
Volume: 85
Pages: 5986-94
Related Report
-
[Journal Article] Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy2011
Author(s)
Kadokura M, Maekawa S, Sueki R, Miura M, Komase K, Shindo H, Amemiya F, Uetake T, Inoue T, Sakamoto M, Nakagawa M, Sakamoto N, Watanabe M, Enomoto N
-
Journal Title
Related Report
-
[Journal Article] Pretreatment prediction of anemia progression by pegylated interferon a2b plus ribavirin combination therapy in chronic hepatitis C infection : Decision-tree analysis2011
Author(s)
Hiramatsu N, Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Sakaguchi F, Tamori A, Kakinuma S, Matsuura K, Izumi N
-
Journal Title
JGastroenterol
Volume: 46
Pages: 1111-19
Related Report
-
[Journal Article] Inhibitory effect of triterpenoid compound, with or without interferon-alpha, on hepatitis C virus infection2011
Author(s)
Watanabe T, Sakamoto N, Nakagawa M, Kakinuma S, Itsui Y, Nishimura-Sakurai Y, Ueyama M, Funaoka Y, Kitazume A, Nitta S, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K, Oooka S, Watanabe M
-
Journal Title
Antimicrob Agent Chemother
Volume: 55
Pages: 2537-45
Related Report
-
[Journal Article] Serum interleukin-6 levels can predict resistance to treatment of chronic hepatitis C infection with pegylated-interferon alpha 2b plus ribavirin2011
Author(s)
Ueyama M, Nakagawa M, Sakamoto N, Onozuka I, Funaoka Y, Watanabe T, Nitta S, Kiyohashi K, Kitazume A, Murakawa M, Nishimura-Sakurai Y, Sekine-Osajima Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M
-
Journal Title
Antivir Ther
Volume: 16
Pages: 1081-1091
Related Report
-
[Journal Article] Association of IL28B polymorphism withresponse to pegylated-interferon alpha plusribavirin combination therapy in patientswith chronic genotype 2 hepatitis C2011
Author(s)
Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Nishimura-Sakurai Y, Itsui Y, Azuma S, Kakinuma S, Hige S, Ito Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M
-
Journal Title
JMedical Virol
Volume: 83
Pages: 871-878
Related Report
-
-
-
[Journal Article] Lnk/Sh2b3 regulatesintegrin aIIbb3 outside-in signaling inplatelets leading to stabilization ofdeveloping thrombus in vivo2010
Author(s)
Takizawa H, Nishimura S, Takayama N, Oda A, Nishikii H, Morita Y, Kakinuma S, Yamazaki S, Okamura S, Tamura N, Goto S, Sawaguchi A, Manabe I, Takatsu K, NakauchiH, Takaki S, Eto K
-
Journal Title
J Clin Invest
Volume: 120
Pages: 179-190
Related Report
-
[Journal Article] Cell culture and in-vivo analyses of plaque-derived cytopathic hepatitis C virus mutants2010
Author(s)
Mishima K, Sakamoto N, Sekine-Osajima Y, Nakagawa M, Itsui Y, Azuma S, Kakinuma S, Tuchiya K, Imamura M, Chayama K, Wakita T, Watanabe M
-
Journal Title
Virology
Volume: 405
Pages: 361-369
Related Report
-
[Journal Article] IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones2010
Author(s)
Suda G, Sakamoto N, Itsui Y, Nakagawa M, Mishima K, Onuki-Karakama Y, Yamamoto M, Funaoka Y, Watanabe T, Kiyohashi K, Nitta S, Azuma S, Kakinuma S, Tuchiya K, Imamura M, Hiraga N, Chayama K, Watanabe M
-
Journal Title
Virology
Volume: 407
Pages: 80-90
Related Report
-
[Journal Article] Inhibition of HCV replication by a specific inhibitor of serin-arginine-rich protein kinase2010
Author(s)
Karakama Y, Sakamoto N, Itsui Y, Nakagawa M, Tasaka-Fujita M, Nishimura-Sakurai Y, Kakinuma S, Oooka S, Azuma S, Tsuchiya K, Onogi H, Hagiwara M, Watanabe M
-
Journal Title
Antimicrob AgentChemother
Volume: 54
Pages: 3179-86
Related Report
-
[Journal Article] ITPA gene variant protects against anemia induced by pegylated interferon-alfa and ribavirin therapy for Japanese patients with chronic hepatitis C2010
Author(s)
Sakamoto N, Tanaka Y, Nakagawa M, Yatsuhashi H, Nishiguchi S, Enomoto N, Azuma S, Nishimura-Sakurai Y, Kakinuma S, Nishida N, Tokunaga K, Honda M, Ito K, Mizokami M, Watanabe M
-
Journal Title
Hepatol Res
Volume: 40
Pages: 1063-1071
Related Report
-
[Journal Article] Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells2010
Author(s)
Nishimura-Sakurai Y, Sakamoto N, Mogushi K, Nagaie S, Nakagawa M, Itsui Y, Sekine-Osajima Y, Tasaka-Fujita M, Onuki-Karakama Y, Suda G, Mishima M, Yamamoto M, Ueyama M, Funaoka Y, Watanabe T, Chen CH, Kakinuma S, Tsuchiya K, Tanaka H, Enomoto N, Watanabe
-
Journal Title
J Gastroentorol
Volume: 45
Pages: 523-36
NAID
Related Report
-
[Journal Article] Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection2010
Author(s)
Nakagawa M, Sakamoto N, Ueyama M, Mogushi K, Nagaie S, Itsui Y, Azuma S, Kakinuma S, Tanaka H, Enomoto N, Watanabe M
-
Journal Title
J Gastroentorol
Volume: 45
Pages: 656-665
NAID
Related Report
-
-
-
-
-
-
-
[Journal Article] Antiviral effects of the interferon-induced protein GBP-1 and its interaction with the hepatitis C virus NS5B protein2009
Author(s)
Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M
-
Journal Title
Hepatology
Volume: 50
Pages: 1727-37
Related Report
-
[Journal Article] Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C2009
Author(s)
Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M
-
Journal Title
NatGenet
Volume: 41
Pages: 1105-1109
Related Report
-
-
-
-
[Journal Article] Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture
Author(s)
Yamamoto M, Sakamoto N, Nakamura T, Itsui Y, Nakagawa M, Nishimura-Sakurai Y, Kakinuma S, Azuma S, Kato T, Wakita T, Watanabe M
-
Journal Title
Related Report
-
-
-
-
[Presentation] ITPA gene variant protects against treatment-induced anemia and improves viral clearance by pegylated interferon-alfa and ribavirin therapy in chronic hepatitis C patients2011
Author(s)
Sakamoto N, Tanaka Y, Nakagawa M, Yatsuhashi H, Nishiguchi S, Enomoto N, Azuma S, Nishimura-Sakurai Y, Kakinuma S, Nishida N, Tokunaga K, Mizokami M, Watanabe M
Organizer
62 nd Annual Meeting of American Association for the Study of Liver Diseases
Place of Presentation
San Francisco, CA. USA
Year and Date
2011-11-05
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-